Literature DB >> 12906368

Lipoprotein (a) in childhood: correlations with family history of cardiovascular disease.

M De Simone1, A Verrotti, M Cappa, L Iughetti, E Di Cesare, M Palumbo, R Bernabei, T Rosato.   

Abstract

The association between lipoprotein (a) [Lp(a)] and cardiovascular diseases is well known. Lp(a) is an independent risk factor for the development of atherosclerosis. Little information concerning Lp(a) during childhood is available. The aim of the present investigation was to determine the Lp(a) concentration in a cohort of children aged between 4 and 15 yr and to correlate Lp(a) with: a) overweight status; b) body fat distribution; c) family history of vascular diseases in their parents and grandparents. Six hundred and eighty-nine children (350 males, 339 females), were enrolled in the study. BMI as index of being overweight was calculated; the waist-to-hip ratio (WHR) and the waist-to-thigh ratio (WTR) were calculated to obtain two anthropometric indexes for the pattern of body fat distribution. The areas of visceral (VAT) and subcutaneous adipose tissue (SAT) were evaluated by MRI at the L4-L5 level in only 30 overweight subjects. The serum of Lp(a), total cholesterol (TC), HDL-cholesterol, LDL-cholesterol and triglycerides were evaluated in the whole population. Moreover, the same biochemical study was performed in 70 children's parents randomly chosen. A structured questionnaire was administered to the children's parents to investigate the presence of cardiovascular disease (CVD) in family stories. Our data show no Lp(a) serum differences between children according to sex, age and body composition. The strong correlation between the children's and the parents' Lp(a) concentrations and the occurrence of CVD in their grandparents suggests that Lp(a) represents an important independent early risk factor for the development of CVD in adulthood. Measurements of Lp(a) in childhood may help to evaluate this risk in subjects with family history of cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12906368     DOI: 10.1007/BF03345196

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  23 in total

1.  Levels of lipoprotein(a) and plasma lipids in Spanish children aged from 4 to 18 years.

Authors:  J A Gómez Gerique; A Porres; D López Martinez; L A Alvarez Sala; E Blazquez; M T Montoya; M De Oya
Journal:  Acta Paediatr       Date:  1996-01       Impact factor: 2.299

2.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

3.  Regional adiposity patterns in relation to lipids, lipoprotein cholesterol, and lipoprotein subfraction mass in men.

Authors:  R B Terry; P D Wood; W L Haskell; M L Stefanick; R M Krauss
Journal:  J Clin Endocrinol Metab       Date:  1989-01       Impact factor: 5.958

Review 4.  Lipoprotein(a) and its role in atherothrombotic disease.

Authors:  G C Howard; S V Pizzo
Journal:  Lab Invest       Date:  1993-10       Impact factor: 5.662

5.  Lp(a) and the risk of coronary heart disease.

Authors:  M Bihari-Varga; G Kostner; A Czinner
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

6.  Relation of coronary artery disease in women < 60 years of age to the combined elevation of serum lipoprotein (a) and total cholesterol to high-density cholesterol ratio.

Authors:  B C Solymoss; M Marcil; E Wesolowska; B M Gilfix; J Lespérance; L Campeau
Journal:  Am J Cardiol       Date:  1993-12-01       Impact factor: 2.778

7.  Body Mass Index variations: centiles from birth to 87 years.

Authors:  M F Rolland-Cachera; T J Cole; M Sempé; J Tichet; C Rossignol; A Charraud
Journal:  Eur J Clin Nutr       Date:  1991-01       Impact factor: 4.016

8.  Black-white differences in serum Lp(a) lipoprotein levels.

Authors:  H J Parra; I Luyéyé; C Bouramoué; C Demarquilly; J C Fruchart
Journal:  Clin Chim Acta       Date:  1987-09-15       Impact factor: 3.786

9.  Apolipoprotein(a) genetic polymorphism and serum lipoprotein(a) concentration in patients with peripheral vascular disease.

Authors:  J Pedro-Botet; M Sentí; T Auguet; X Nogués; J Rubiés-Prat; C Aubó; F Vidal-Barraquer
Journal:  Atherosclerosis       Date:  1993-12       Impact factor: 5.162

10.  Lipoprotein (a) concentrations as risk indicators for atherosclerosis.

Authors:  G M Kostner; A Czinner; K H Pfeiffer; M Bihari-Varga
Journal:  Arch Dis Child       Date:  1991-09       Impact factor: 3.791

View more
  2 in total

1.  Lipoprotein (a): Examination of Cardiovascular Risk in a Pediatric Referral Population.

Authors:  Omar Qayum; Noor Alshami; Chizitam F Ibezim; Kimberly J Reid; Janelle R Noel-MacDonnell; Geetha Raghuveer
Journal:  Pediatr Cardiol       Date:  2018-06-13       Impact factor: 1.655

2.  Prevalence and status of Lipoprotein (a) among Lebanese school children.

Authors:  Marie-Hélène Gannagé-Yared; Christina Lahoud; Nada Younes; Rima Chedid; Ghassan Sleilaty
Journal:  Sci Rep       Date:  2020-11-26       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.